Position in ARGX
as of Mar 31, 2026
· filed May 6, 2026
Position Value
$688,625
-$45,523 QoQ
Shares Held
943
+8.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ARGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026INTRUST BANK NA holds $7,434,440 across 12 Biotechnology names. ARGX ranks #4 (9.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,902 | $1,742,398 | |
| 2 | FTRE |
Fortrea Holdings Inc.
|
123,739 | $1,165,621 | |
| 3 | AXSM |
Axsome Therapeutics, Inc.
|
4,508 | $761,941 | |
| 4 | ARGX |
Argenx SE
This page
|
943 | $688,625 | |
| 5 | INSM |
INSMED Inc
|
3,518 | $575,262 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
623 | $481,354 | |
| 7 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
863 | $451,754 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
6,942 | $448,661 |
All Filings in ARGX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $688,625 | 943 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $734,148 | 873 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $548,744 | 744 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $345,614 | 627 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $420,223 | 710 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $383,145 | 623 | Shares | Sole | 2025-02-12 | |
| No filing history on record for this holder in this stock. | ||||||